Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up

by Francesco Menzella, Nicola Facciolongo, Roberto Piro, Debora Formisano, Alberto Roggeri, Anna Simonazzi, Claudia Castagnetti, Cristiano Carbonelli, Luigi Zucchi
Published 2012-04-01